Sitagliptin D4 is supplied with detailed characterization data compliant with regulatory guideline. Sitagliptin D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sitagliptin.
Information
Sitagliptin-D4 is a labelled analog of Sitagliptin , which is a dipeptidyl-peptidase 4 (DPP-4) inhibitor useful as an anti-diabetic for the treatment of type 2 diabetes.